News
Adults on dupilumab for severe chronic rhinosinusitis with nasal polyps had better outcomes than those who used omalizumab, ...
[A]lthough our findings found that there is insufficient evidence to suggest that dupilumab use is associated with joint pain, the prevalence of joint pain observed among patients treated with ...
The Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult patients with bullous pemphigoid.
4h
News Medical on MSNInflammatory cells remain in the blood after treatment of severe asthma, study showsBiological drugs have improved the lives of many people with severe asthma. However, a new study from Karolinska Institutet ...
Equipped with a new CEO, Vor Bio is transitioning into an autoimmune player, leaving cell and gene therapy behind.
While biological drugs or biologics have improved the lives of many people with severe asthma, a new study shows that some ...
Bio-Thera Solutions & SteinCares expand partnership to commercialize biosimilars to treat inflammatory diseases across Latin America: Guangzhou, China Thursday, June 26, 2025, 12: ...
While biological drugs (biologics) have significantly improved the quality of life for individuals with severe asthma, new ...
Nektar, which accused Lilly of making errors in its analysis of the data, forged ahead with the programme and started the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results